Beauty Skin Corp. (KOSDAQ:406820)
South Korea · Delayed Price · Currency is KRW 11,570
-40 (-0.34%)
At close: Oct 2, 2025
Beauty Skin Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 67,541 | 80,871 | 80,904 | 58,937 | 41,164 | 37,102 | |
Revenue Growth (YoY) | -24.66% | -0.04% | 37.27% | 43.18% | 10.95% | - |
Cost of Revenue | 63,277 | 72,605 | 73,716 | 43,350 | 35,711 | 30,473 |
Gross Profit | 4,264 | 8,266 | 7,188 | 15,587 | 5,453 | 6,629 |
Selling, General & Admin | 8,097 | 8,838 | 9,662 | 11,231 | 2,064 | 1,934 |
Research & Development | 330.14 | 266.8 | 211 | 187.53 | 205.54 | 197.35 |
Other Operating Expenses | 203.46 | 214.07 | 266.74 | 255.3 | 96.22 | 103.79 |
Operating Expenses | 11,220 | 9,479 | 13,738 | 11,546 | 2,240 | 2,518 |
Operating Income | -6,956 | -1,213 | -6,550 | 4,040 | 3,213 | 4,111 |
Interest Expense | -1,649 | -1,649 | -1,227 | -1,015 | -272.21 | -422.5 |
Interest & Investment Income | 116.05 | 116.05 | 19.57 | 7.88 | 8.25 | 9.34 |
Currency Exchange Gain (Loss) | 61.93 | 61.93 | 288.84 | -7.97 | 241.4 | -206.4 |
Other Non Operating Income (Expenses) | -3,301 | -1,904 | -144.77 | -4.28 | 23.08 | 86.95 |
EBT Excluding Unusual Items | -11,728 | -4,588 | -7,613 | 3,021 | 3,214 | 3,579 |
Impairment of Goodwill | -844.05 | -844.05 | -2,332 | -12.4 | - | - |
Gain (Loss) on Sale of Investments | -5.29 | -5.29 | 258.97 | -4.64 | -23.55 | -16.49 |
Gain (Loss) on Sale of Assets | -4.05 | -4.05 | -36.28 | - | -2.64 | - |
Other Unusual Items | - | - | - | 276.32 | - | - |
Pretax Income | -12,081 | -4,942 | -9,723 | 3,280 | 3,188 | 3,562 |
Income Tax Expense | -649.18 | 734.32 | -1,073 | 287.79 | 767.7 | 618.23 |
Earnings From Continuing Operations | -11,432 | -5,676 | -8,650 | 2,992 | 2,420 | 2,944 |
Minority Interest in Earnings | 696.95 | 613.58 | 10.3 | 363.4 | - | - |
Net Income | -10,735 | -5,062 | -8,640 | 3,356 | 2,420 | 2,944 |
Net Income to Common | -10,735 | -5,062 | -8,640 | 3,356 | 2,420 | 2,944 |
Net Income Growth | - | - | - | 38.67% | -17.80% | - |
Shares Outstanding (Basic) | 4 | 4 | 3 | 3 | 3 | 0 |
Shares Outstanding (Diluted) | 4 | 4 | 3 | 3 | 3 | 0 |
Shares Change (YoY) | 3.71% | 7.52% | 4.42% | 16.14% | 602.11% | - |
EPS (Basic) | -3064.40 | -1432.45 | -2628.55 | 1089.23 | 893.53 | 7626.05 |
EPS (Diluted) | -3064.40 | -1432.45 | -2628.55 | 1066.00 | 893.00 | 7626.05 |
EPS Growth | - | - | - | 19.37% | -88.29% | - |
Free Cash Flow | 2,689 | 8,246 | -18,679 | 2,958 | 3,677 | 2,718 |
Free Cash Flow Per Share | 767.72 | 2333.28 | -5682.77 | 939.67 | 1356.59 | 7040.02 |
Gross Margin | 6.31% | 10.22% | 8.88% | 26.45% | 13.25% | 17.87% |
Operating Margin | -10.30% | -1.50% | -8.10% | 6.86% | 7.81% | 11.08% |
Profit Margin | -15.89% | -6.26% | -10.68% | 5.69% | 5.88% | 7.94% |
Free Cash Flow Margin | 3.98% | 10.20% | -23.09% | 5.02% | 8.93% | 7.32% |
EBITDA | -5,056 | 540.62 | -4,740 | 5,196 | 3,828 | 4,763 |
EBITDA Margin | -7.49% | 0.67% | -5.86% | 8.82% | 9.30% | 12.84% |
D&A For EBITDA | 1,900 | 1,754 | 1,810 | 1,155 | 614.33 | 651.6 |
EBIT | -6,956 | -1,213 | -6,550 | 4,040 | 3,213 | 4,111 |
EBIT Margin | -10.30% | -1.50% | -8.10% | 6.86% | 7.81% | 11.08% |
Effective Tax Rate | - | - | - | 8.77% | 24.08% | 17.36% |
Advertising Expenses | - | 1,516 | 2,184 | 3,794 | 3 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.